Bone Biologics Corporatio... (BBLG)
NASDAQ: BBLG
· Real-Time Price · USD
2.13
-0.02 (-0.93%)
At close: Sep 25, 2025, 3:59 PM
2.14
0.43%
After-hours: Sep 25, 2025, 05:18 PM EDT
-0.93% (1D)
| Bid | 2.1 |
| Market Cap | 3.82M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.22M |
| EPS (ttm) | -21.39 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | -1.23 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 2.14 |
| Volume | 54,862 |
| Avg. Volume (20D) | 2,467,442 |
| Open | 2.11 |
| Previous Close | 2.15 |
| Day's Range | 2.10 - 2.17 |
| 52-Week Range | 1.95 - 16.12 |
| Beta | 1.30 |
| Ex-Dividend Date | n/a |
About BBLG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBLG
Website n/a
3 weeks ago
+37.68%
Bone Biologics shares are trading higher after the...
Unlock content with
Pro Subscription
3 months ago
+10.1%
Bone Biologics shares are trading higher after the compnay announced it filed a USPTO patent for rhNELL-1.
2 months ago · businesswire.com
Bone Biologics Announces Closing of $5.0 Million Public OfferingBURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...
3 months ago · businesswire.com
Bone Biologics Announces Pricing of $5.0 Million Public OfferingBURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...
3 months ago · businesswire.com
Bone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsBURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...